COVID-19大流行对美国肝细胞癌住院患者的影响

数据集获取（Figshare）

• 源站标题：Impact of the COVID-19 pandemic on hospitalizations with hepatocellular carcinoma in the United States
• DOI：10.6084/m9.figshare.25245146.v1
• 发布日期：2024-02-19
• 文件数：2 个
• 文件总体积：984.33 KB
• 源站页面：https://tandf.figshare.com/articles/dataset/Impact_of_the_COVID-19_pandemic_on_hospitalizations_with_hepatocellular_carcinoma_in_the_United_States/25245146

命令行下载

curl -L -o "ierh_a_2319580_sm2728.tif" "https://ndownloader.figshare.com/files/44600438"
curl -L -o "ierh_a_2319580_sm2727.docx" "https://ndownloader.figshare.com/files/44600441"

文件清单

• ierh_a_2319580_sm2728.tif（960.77 KB）
• ierh_a_2319580_sm2727.docx（23.56 KB）

文件总体积 984.33 KB（源站 API 实测）。

数据加载示例（图像类）

from PIL import Image
import glob, os

files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)

# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path)  # 要求 子目录=类别

目录组织与标注格式以源站说明和下载后实际文件为准。

数据说明

We studied the temporal trends of hepatocellular carcinoma (HCC)-related hospitalizations and potential predictors of in-hospital mortality around the COVID-19 pandemic.
Using the International Classification of Diseases code, we used the National Inpatient Sample 2019–2020 and defined HCC and its underlying etiology. To assess the impact of the COVID-19 pandemic on hospitalization and in-hospital mortality, the study period was divided into the pre-COVID-19 era (2019 Q1–2020 Q1) and the COVID-19 era (2020 Q2–2020 Q4). Quarterly trends in etiology-based hospitalizations with HCC and predictors of in-hospital mortality among hospitalizations with HCC were determined.
Hospitalization rates for HCC, as well as viral hepatitis-related HCC hospitalization rates, remained stable, while hospitalizations with alcohol-related liver disease (ALD, quarterly percentage change [QPC]: 2.1%; 95% confidence interval [CI]: 0.1%-4.2%) increased steadily. Hospitalization related to nonalcoholic fatty liver disease (NAFLD)-related HCC increased significantly steeper in the COVID-19 era (QPC: 6.6%; 95% CI: 4.0%-9.3%) than in the pre-COVID-19 era (QPC: 0.7%; 95% CI: 0.2%-1.3%). COVID-19 infection was independently associated with in-hospital mortality among hospitalizations with HCC (odds ratio: 1.94, 95% CI: 1.30–2.88).
Hospitalization rates for viral hepatitis-related HCC remained stable, while those for HCC due to ALD and NAFLD increased during the COVID-19 pandemic.

许可

CC BY 4.0

引用

学术使用请引用 DOI 10.6084/m9.figshare.25245146.v1（source: https://tandf.figshare.com/articles/dataset/Impact_of_the_COVID-19_pandemic_on_hospitalizations_with_hepatocellular_carcinoma_in_the_United_States/25245146）。